Cheng S-S, Jiang J-G, Lin S-C, Yu Y-H, Chang TW, Lim C, Yu Y-B, Chu H-M. TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity. haematol [Internet]. 2026Apr.1 [cited 2026Apr.2];111(4):1474-7. Available from: https://haematologica.org/article/view/12982